Squamous Cell Carcinoma of the Skin
Oncology·MeSH: Turcot syndrome
Prevalence
0.5 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| ph-762 | Phio Pharmaceuticals Corp. (PHIO) |
Frequently asked questions
How many drugs are in development for Squamous Cell Carcinoma of the Skin?
BioSniper tracks 1 drug in development for Squamous Cell Carcinoma of the Skin across 1 company.
How many clinical trials target Squamous Cell Carcinoma of the Skin?
There are 3 clinical trials targeting Squamous Cell Carcinoma of the Skin tracked by BioSniper.
What is the prevalence of Squamous Cell Carcinoma of the Skin?
The estimated prevalence of Squamous Cell Carcinoma of the Skin is approximately 0.5 per 100,000 population.
Deep-dive into Squamous Cell Carcinoma of the Skin
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis